Completed PHASE4 INTERVENTIONAL 2-arm NCT00596882

Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study

Sponsor: Pennsylvania Department of Health

Updated 5 times since 2017 Last updated: Dec 1, 2009 Started: Feb 29, 2008 Primary completion: Jun 30, 2009 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00596882, this PHASE4 trial focuses on Smoking Cessation and remains completed. Sponsored by Pennsylvania Department of Health, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pennsylvania Department of Health
Pfizer
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States